Covered recipient · General Payments record
FOLUKE UCHE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,840.73
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $700.14 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $254.33 | 7 |
| Lilly USA, LLC | $165.92 | 6 |
| Novo Nordisk AS | $104.45 | 5 |
| GlaxoSmithKline, LLC. | $49.66 | 3 |
| Acerta Pharma LLC | $38.62 | 2 |
| Amgen Inc. | $29.25 | 1 |
| Janssen Pharmaceuticals, Inc | $23.59 | 1 |
| Itamar Medical Inc | $17.17 | 1 |
| DEXCOM, INC. | $17.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $29.25 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117403668 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.02 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105868341 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.60 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374666 | CMS |
| Dexcom, Inc. | $17.15 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153300388 | CMS |
| GlaxoSmithKline, LLC. | $16.14 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116259105 | CMS |
| GlaxoSmithKline, LLC. | $17.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116244978 | CMS |
| GlaxoSmithKline, LLC. | $15.73 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116584623 | CMS |
| Itamar Medical Inc | $17.17 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154006116 | CMS |
| Janssen Pharmaceuticals, Inc | $23.59 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078099744 | CMS |
| Lilly USA, LLC | $11.12 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134989910 | CMS |
| Lilly USA, LLC | $12.26 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134980872 | CMS |
| Lilly USA, LLC | $15.60 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134994312 | CMS |
| Lilly USA, LLC | $15.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134989912 | CMS |
| Lilly USA, LLC | $93.87 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134982318 | CMS |
| Lilly USA, LLC | $17.63 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134980874 | CMS |
| Novo Nordisk Inc | $17.56 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930866 | CMS |
| Novo Nordisk Inc | $19.58 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097215733 | CMS |
| Novo Nordisk Inc | $23.64 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097603056 | CMS |
| Novo Nordisk Inc | $21.23 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097828176 | CMS |
| Novo Nordisk Inc | $22.44 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096607557 | CMS |
| PFIZER INC. | $26.73 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130985477 | CMS |
| PFIZER INC. | $17.44 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131507533 | CMS |
| PFIZER INC. | $19.29 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132010914 | CMS |
| PFIZER INC. | $24.42 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131953839 | CMS |
| PFIZER INC. | $19.68 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132098775 | CMS |
| PFIZER INC. | $118.24 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131269102 | CMS |
| PFIZER INC. | $28.53 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130988381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.